Today, the American Association for Cancer Research (AACR) released its ninth annual Cancer Progress Report. The report highlights how research largely supported by federal investments in the National Institutes of Health (NIH) is spurring improvements in public health and innovative breakthroughs across the spectrum of cancer care.Read More
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to experience a truly comprehensive training in breast cancer. During my tenure, I decided to take advantage of opportunities offered to me outside of the lab to learn about cancer from every angle, including attending weekly breast tumor boards and presenting my work to the Georgetown Breast Cancer Advocates (GBCA).
I’ll never forget at the end of my presentation with GBCA, one of the advocates, Jamie, asked what the side effects were for a new treatment I was proposing. I was proud that I had done some research on this and confidently stated, “they are the same as tamoxifen,” a commonly used breast cancer treatment.Read More
Metastasis is defined as the spreading of cancer cells from the place where they first formed to another part of the body. Once cancer has metastasized, it can become more difficult to treat, increasing the chances that a patient will die of the disease.Read More
The AACR-Bayer Innovation and Discovery Grants program supports researchers who are seeking to develop new treatment options for cancers with high unmet medical need. The program aims to encourage innovation and translation of ideas from basic research into novel drugs, and to foster collaborations between academic groups and the pharmaceutical industry.Read More
Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers with a unique opportunity to accelerate their careers. The Fellowships offer £300,000/$400,000 over four years to support the development of recently graduated PhDs and early-career postdocs into independent researchers at top institutions in the United Kingdom and the United States.Read More
In addition to world-class training in patient care, physician-scientists also require experience in laboratory and clinic-based research to ensure that they stay up-to-date with the pace of medical progress. As such, many fellowship programs offer dedicated research time, often for a year or longer, to these young physician-scientists, providing them with sufficient expertise to contribute to laboratory-based research projects or clinical trials that will advance medical practice and improve patient outcomes.Read More
Today, September 24, 2018, is World Cancer Research Day. The American Association for Cancer Research (AACR) is proud to join cancer organizations, associations, and researchers from around the world in supporting this global initiative that aims to raise awareness about the importance of cancer research for saving lives.Read More
Today, the American Association for Cancer Research (AACR) released its eighth annual Cancer Progress Report. The report highlights how federally funded research that provides a deep understanding of the complexities of cancer is spurring advances across the clinical cancer care continuum and improving survival and quality of life for people around the world.Read More
For many aspiring investigators, pursuing a career in cancer research can be a complex exploration of self and purpose.
In this touching and inspiring piece published in The New York Times, a former AACR Undergraduate Scholar Awardee, Mya Roberson, now a doctoral student at the University of North Carolina Gillings School of Global Public Health, shares how her participation in the AACR Annual Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved helped her realize the meaning in her research.Read More
This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at supporting pediatric cancer research. The legislation calls for expanding the collection of patient biospecimens and records, improving surveillance, and investigating pediatric survivorship.Read More